ZEB2 has previously been confirmed to be associated with the malignant phenotype of glioma [72], and the expression level of ZEB1 was significantly increased in glioma tissues compared to normal brain tissues, being positively correlated with WHO glioma classification [73]. Here, ZEB2 is linked to central nervous system cancer.